Shengnuo Pharmaceutical-B (02257) rebounded more than 10%. Previously, it plummeted 33% for 2 consecutive trading days to hit a new low since listing. As of press release, it had risen 10.50% to HK$14.10, with a turnover of HK$4.01 million.
The Zhitong Finance App learned that Shengnuo Pharmaceutical-B (02257) rebounded more than 10%. Previously, it plummeted 33% for 2 consecutive trading days to hit a new low since listing. As of press release, it had risen 10.50% to HK$14.10, with a turnover of HK$4.01 million.
According to the news, Shengnuo Pharmaceutical-B issued an announcement. The company's board of directors learned about recent unusual fluctuations in the stock price of the company's shares. After making reasonable inquiries about the company concerned, the board confirmed that it was unaware of any reason for the share price fluctuation, or any information that must be published to avoid false markets in the company's securities, or any insider information required to be disclosed under Part XIVA of the Securities and Futures Ordinance, Chapter 571 of the Laws of Hong Kong.
The board of directors confirmed that there were no significant adverse changes in the Group's business operations or the development of the company's core products. The management team remains confident about the Group's long-term development prospects.